posted on 2025-01-02, 07:45authored byChan Wang, Yingyi Quan, Jiang Jiang, Han Yu, Jia Liu, Wei Tang, Xinyue Li, Shouju Wang, Da Huo, Guang-Liang Jiang, Yang Yang, Qingqing Ding
The protein corona effect refers to the phenomenon wherein
nanomaterials
in the bloodstream are coated by serum proteins, yet how protein coronated
nanomaterials interact with blood vessels and its toxicity implications
remain poorly understood. In this study, we investigated protein corona-related
vessel toxicity by using an all-humanized assay integrating blood
vessel organoids and patient-derived serum. Initially, we screened
various nanomaterials to discern how parameters including size, morphology,
hydrophobicity, surface charge, and chirality-dependent protein corona
difference influence their uptake by vessel organoids. For nanomaterials
showing substantial differences in vessel uptake, their protein corona
was analyzed by using label-free mass spectra. Our findings revealed
the involvement of cancer staging-related cytoskeleton components
in mediating preferential uptake by cells, including endothelial and
mural cells. Additionally, a transcriptome study was conducted to
elucidate the influence of nanomaterials. We confirmed that protein
coronated nanomaterials provoke remodeling at both transcriptional
and translational levels, impacting pathways such as PI3K-Akt/Hippo/Wnt,
and membraneless organelle integrity, respectively. Our study further
demonstrated that the remodeling potential of patient-derived protein
coronated nanomaterials can be harnessed to synergize with antiangiogenesis
therapeutics to improve the outcomes. We anticipate that this study
will provide guidance for the safe use of nanomedicine in the future.